Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ARDS

Res Commun Mol Pathol Pharmacol. 2002;111(5-6):245-51.

Abstract

The levels of surfactant protein-A (SP-A) and surfactant protein-D (SP-D) in the serum of patients with septic acute respiratory distress syndrome (ARDS) were determined. Patients with sepsis without ARDS were examined as controls. The mean serum SP-A level in the former group was 37.6 +/- 16.2 ng/ml and in the latter group was 31.8 +/- 9.6 ng/ml. The difference between the two groups was not statistically significant. The maximum serum SP-D level was 83.0 +/- 33.9 ng/ml in the control group of patients without ARDS, and 476.3 +/- 391.2 ng/ml in the patients with ARDS. The level in the latter population was significantly higher than that in the former population. No significant correlation was observed between the SP-A and SP-D levels. These results suggest that the serum SP-D levels may serve as a good diagnostic indicator of ARDS in patients with sepsis.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Surfactant-Associated Protein A / metabolism*
  • Pulmonary Surfactant-Associated Protein D / metabolism*
  • Respiratory Distress Syndrome / etiology
  • Respiratory Distress Syndrome / metabolism*
  • Sepsis / complications
  • Sepsis / metabolism*

Substances

  • Biomarkers
  • Pulmonary Surfactant-Associated Protein A
  • Pulmonary Surfactant-Associated Protein D